Vanguard Personalized Indexing Management, LLC Bolt Biotherapeutics, Inc. Transaction History

Vanguard Personalized Indexing Management, LLC

$8.6 Billion
Q2 2025

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 09, 2022	SELL	$1.41 - $2.91 $25,215 - $52,039	-17,883 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.74 - $4.82 $48,999 - $86,196	17,883 New	17,883 $49,000

Others Institutions Holding BOLT

# of Institutions

Shares Held

17.4M

Call Options Held

Put Options Held

Tang Capital Management LLC San Diego, CA

3.81M
Shares

$21.4 Million
0.1% of portfolio
Vivo Capital, LLC Palo Alto, CA

3.52M
Shares

$19.7 Million
0.38% of portfolio
Sofinnova Investments, Inc. Menlo Park, CA

2.75M
Shares

$15.4 Million
0.08% of portfolio
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA

1.89M
Shares

$10.6 Million
1.06% of portfolio
Vanguard Group Inc Valley Forge, PA

1.17M
Shares

$6.55 Million
0.0% of portfolio

View Full List

About Bolt Biotherapeutics, Inc.

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $211M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

More about BOLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Account